Show simple item record

dc.contributor.authorStrenk, Meghan
dc.contributor.authorFuller, Lisa
dc.contributor.authorIannone, Alex
dc.contributor.authorTaylor, Holland
dc.contributor.authorMortenson, Luke, Ph.D.
dc.contributor.authorBrown, Keri
dc.contributor.authorClark, David
dc.contributor.authorStrom, David, Ph.D.
dc.contributor.authorHenry, Matt, Ph.D.
dc.contributor.authorNelson, Brandon
dc.date.accessioned2005-06-10T16:40:26Z
dc.date.available2005-06-10T16:40:26Z
dc.date.issued2005-06-10T16:40:26Z
dc.identifier.urihttp://hdl.handle.net/2092/263
dc.descriptionMegan Strenk graduated from Drake in May 2005, with a B.S. in Biochemistry, Cell and Molecular Biology. Lisa Fuller is currently a Pharmacy student at Drake.en
dc.description.abstractIn recent years, complementary and alternative medicine (CAM) has become more widespread in the treatment of a variety of illnesses. Several of these alternative herbal therapies claim that they are effective in fighting cancer, though these claims have yet to be supported by the FDA. It is our goal to develop an assay that can evaluate the efficacy of some of these herbal treatments against cancer. Thus far, our main focus has been on the compound hydroxycinnamoaldehyde (HCA), which is the active ingredient in the herb Rou Gui. We have looked at the efficacy of this drug using two methods. The first, flow cytometry, uses DNA to determine cell death. The second, a caspase-3 assay, surveys for a protein present in early apoptosis. These two assays have allowed us to find a dose-response curvefor 32D cells using two traditional concer treatments (Taxol and Doxorubicin), each with and withoutthe addition of HCA. The difference in the curves for each drug with and without HCA will tell us whether or not the herbal has an effect for that treatment.en
dc.description.sponsorshipDrake University, College of Arts and Sciences, Department of Biochemistry, Cell and Molecular Biology, and the College of Pharmacy. Des Moines University, Department of Physiology and Pharmacology.en
dc.format.extent988808 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.relation.ispartofseriesDUCURS 2005;24
dc.subjectCancer--Alternative treatmenten
dc.subjectAlternative medicinceen
dc.subjectHerbs--Therapeutic useen
dc.subjectPhytotherapyen
dc.title"Therapeutic efficacy of herbal extracts for cancer chemotherapy"en
dc.title.alternative"2' hydroxycinnamaldehyde exhibits potential as an anticancer chemotherapeutic agent"en
dc.typePresentationen


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • DUCURS
    Poster sessions and presentation from the Drake University Conference on Undergraduate Research in the Sciences held each April at Olmsted Center on the Drake campus.

Show simple item record